KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

DAFNA Capital Management LLC's Holding History (CIK: 0001389933)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 50,000 Value ($000) $119 Avg Close — Range —
Q3 2023
Shares 105,179 Value ($000) $147 Avg Close — Range —
Q2 2023
Shares 80,179 Value ($000) $243 Avg Close — Range —
Q1 2023
Shares 81,008 Value ($000) $506 Avg Close — Range —
Q4 2022
Shares 71,008 Value ($000) $433 Avg Close — Range —
Q3 2022
Shares 78,074 Value ($000) $933 Avg Close — Range —
Q2 2022
Shares 224,451 Value ($000) $2,830 Avg Close — Range —
Q1 2022
Shares 148,151 Value ($000) $1,668 Avg Close — Range —
Q4 2021
Shares 106,453 Value ($000) $1,886 Avg Close — Range —
Q3 2021
Shares 106,453 Value ($000) $2,451 Avg Close — Range —
Q2 2021
Shares 54,415 Value ($000) $1,267 Avg Close — Range —
Q1 2021
Shares 52,915 Value ($000) $1,649 Avg Close — Range —
Q4 2020
Shares 68,121 Value ($000) $2,710 Avg Close — Range —